Mercy Regional Cancer Center at Mercy Hospital
Port Huron, Michigan, United States
Cancer treatment center in Port Huron, Michigan
2601 Electric Ave, Port Huron, MI 48060
About Mercy Regional Cancer Center at Mercy Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
56
SWOG Cancer Research Network
39
Radiation Therapy Oncology Group
9
Eastern Cooperative Oncology Group
8
NSABP Foundation Inc
6
ECOG-ACRIN Cancer Research Group
5
Gynecologic Oncology Group
2
ETOP IBCSG Partners Foundation
1
Clinical Trials at Mercy Regional Cancer Center at Mercy Hospital
During the past decade, Mercy Regional Cancer Center at Mercy Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 87 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
2001-07-01
2011-07-01
Terminated
65
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
2001-06-01
2008-11-01
Terminated
14
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mercy Regional Cancer Center at Mercy Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 56 trials, followed by "SWOG Cancer Research Network" with 39 trials
sponsored, "Radiation Therapy Oncology Group" with 9 trials sponsored, "Eastern Cooperative Oncology Group" with 8 trials sponsored and "NSABP Foundation Inc"
with 8 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Regional Cancer Center at Mercy Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Mercy Regional Cancer Center at Mercy Hospital
According to Clinical.Site data, the most researched conditions in "Mercy Regional Cancer Center at Mercy Hospital" are
"Breast Cancer" (28 trials), "Lung Cancer" (24 trials), "Prostate Cancer" (11 trials), "Lymphoma" (10 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (10 trials). Many other conditions were trialed in "Mercy Regional Cancer Center at Mercy Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Regional Cancer Center at Mercy Hospital
Most popular intervention types in "Mercy Regional Cancer Center at Mercy Hospital" are "Drug" (93 trials), "Other" (40 trials), "Biological" (35 trials), "Radiation" (20 trials) and "Procedure" (8 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (22 trials), "bevacizumab" (13 trials), "carboplatin" (12 trials), "cyclophosphamide" (10 trials) and "radiation therapy" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Regional Cancer Center at Mercy Hospital
The vast majority of trials in "Mercy Regional Cancer Center at Mercy Hospital" are
97 trials for "All" genders, 20 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at Mercy Regional Cancer Center at Mercy Hospital
Currently, there are NaN active trials in "Mercy Regional Cancer Center at Mercy Hospital".
undefined are not yet recruiting,
undefined are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 103 completed trials in Mercy Regional Cancer Center at Mercy Hospital,
undefined suspended trials,
and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Regional Cancer Center at Mercy Hospital, 4 "Phase 1"
clinical trials were conducted, 62 "Phase 2" clinical
trials and 46 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".